Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00663091

A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers — WPP-201  

Venous Leg Ulcers Clinical Trial

Official title:
A Prospective, Randomized Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers

Clinical Trial Summary

To test safety and efficacy of Bacteriophage on Venous Leg Ulcers.

Clinical Trial Description

This is a prospective, randomized, controlled double blind study in patients with full thickness venous leg ulcers of greater than 30 days duration evaluating the safety of WPP-201 on the healing of those wounds. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00663091
Study type Interventional
Source Southwest Regional Wound Care Center
Contact
Status Completed
Phase Phase 1
Start date September 2006
Completion date May 2008
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02609594 - Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers N/A
Unknown status NCT02011724 - A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® Phase 4
Active, not recruiting NCT01737762 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 Phase 3
Completed NCT02222467 - Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers N/A
Completed NCT01199588 - A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers Phase 2
Withdrawn NCT00953563 - The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers N/A
Enrolling by invitation NCT02047084 - Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Completed NCT02020746 - Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds Phase 2
Terminated NCT02154087 - A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers Phase 2
Completed NCT02470806 - Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT) N/A
Suspended NCT02577120 - Wound Healing Endpoint and Recurrence Phase 4
Completed NCT01743053 - A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers Phase 4
Recruiting NCT02312518 - A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers N/A
Recruiting NCT02352454 - Effectiveness of Aurix Therapy in Venous Leg Ulcers N/A
Withdrawn NCT02940587 - Effectiveness of Aurix Therapy in Venous Leg Ulcers Phase 4
Completed NCT01036438 - Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers Phase 4
Unknown status NCT02224300 - Nursing Care With Patients With Venous Leg Ulcers Phase 2
Completed NCT01656889 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers Phase 3
Completed NCT02422017 - Topical Timolol Benefit in Venous Ulcers Phase 2